390 filings
Page 13 of 20
8-K
t5zow5xq 6ba83l491
14 Nov 17
Regulation FD Disclosure
12:00am
8-K
pjcnrzmuqs
9 Nov 17
Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated Financials
12:00am
8-K
yiet1c tu
3 Nov 17
Pulmatrix Appoints Dr. James Roach as Chief Medical Officer
12:00am
CT ORDER
4lm9uggwcic844 floh
19 Sep 17
Confidential treatment order
12:00am
8-K
ay185b28hlrj dze
11 Sep 17
Regulation FD Disclosure
12:00am
8-K
bfk4qq
7 Sep 17
The agreement will accelerate the development of the innovative inhaled drug
12:00am
8-K
m2bjagaf
15 Aug 17
Regulation FD Disclosure
12:00am
8-K
el86czc4o
4 Aug 17
Pulmatrix Provides 2017 CompanyYear-to-Date Highlights and Q2 2017 Updated Financials
12:00am
8-K
5ih8fmu3b fa
3 Aug 17
Regulation FD Disclosure
12:00am
8-K
7twv78phpwer7 c6
15 Jun 17
Amit D. Munshi Joins Pulmatrix’s Board of Directors
12:00am
8-K
umjwlv 3i3audnpgouz
13 Jun 17
The novel compounds target an enzyme involved in both inflammation and cancer, and may offer a new approach for treating respiratory diseases
12:00am
8-K
7wpjy25xr07i 1olu
9 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
74n6fr
5 May 17
Pulmatrix Reports Q1 2017 Financial Results
12:00am
DEFA14A
eirrwwx
28 Apr 17
Additional proxy soliciting materials
12:00am
424B5
n8tc efqci4j5
17 Mar 17
Prospectus supplement for primary offering
12:00am
8-K
mgsnts wg
17 Mar 17
Entry into a Material Definitive Agreement
12:00am